The latest immunotherapy news and developments
Scientists from Scripps Research have enhanced an existing immunotherapy by removing the sugar coating surrounding…
A new study has found that pancreatic cancer cells are different based on their location…
Moffitt Cancer Center has launched a pioneering clinical trial for patients with late-stage non-small cell lung cancer whose…
A new study examines the development of two machine learning models to classify the immunophenotype…
New research from the University of Pittsburgh, USA, explains why metastatic uveal melanoma is resistant to conventional…
In a new study published today in Nature Biomedical Engineering, researchers at The University of Texas…
The U.S. Food and Drug Administration (FDA) has approved the immunotherapy-boosting drug N-803, to be…
A pilot study led by UCLA Health Jonsson Comprehensive Cancer Center (USA) investigators suggests that…
In a small, investigator-initiated phase 2 study by Dana-Farber Cancer Institute investigators (USA), a novel…
Researchers from The University of Texas MD Anderson Cancer Center, USA, presented encouraging findings today from…